Stem Cells Translational Medicine.In their paper, Prof. Dilogo and his team, specialists in stem cell therapy at Cipto Mangunkusumo Central Hospital in Jakarta, describe a clinical trial of the treatment they devised.Between May 1 and October 10, 2020, the trial randomly assigned 40 patients with COVID-19 to receive either injections of umbilical cord stem cells in saline solution or injections of saline alone.
All the patients had severe pneumonia and were on ventilators in the ICU at four hospitals in Jakarta.Out of the 20 patients who received injections of stem cells, 10 survived, while only 4 out of 20 patients survived in the control group. The researchers report that among patients with underlying health conditions, those who.